Cash from Operations (Quarterly) Chart

Historical Cash from Operations (Quarterly) Data

View and export this data back to 2020. Start Trial.
Date Value
September 30, 2026 -16.29M
June 30, 2026 -18.21M
March 31, 2026 -26.00M
December 31, 2025 -10.43M
September 30, 2025 -13.28M
June 30, 2025 -17.26M
March 31, 2025 -22.54M
December 31, 2024 -19.37M
September 30, 2024 -14.65M
June 30, 2024 -2.945M
March 31, 2024 -20.71M
December 31, 2023 -15.25M
Date Value
September 30, 2023 -17.58M
June 30, 2023 -11.03M
March 31, 2023 -26.84M
December 31, 2022 -17.39M
September 30, 2022 -20.56M
June 30, 2022 -23.71M
March 31, 2022 -27.68M
December 31, 2021 -12.17M
September 30, 2021
June 30, 2021
March 31, 2021
December 31, 2020 -3.167M

Cash From Operations Definition

Represents the net cash flow from the company's business operations.

Read full definition.

Cash from Operations (Quarterly) Range, Past 5 Years

View Cash from Operations (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Operations (Quarterly) Benchmarks

View Cash from Operations (Quarterly) Benchmarks
Start Trial
Cypherpunk Technologies, Inc. -2.902M
Cue Biopharma, Inc. -10.08M
Yarrow Bioscience, Inc. -89.96M
Faeth Therapeutics, Inc. -13.00M
Indaptus Therapeutics, Inc. -1.245M